Small logo Subscribe to leading news on impact investing. Learn More
The Brief Originals Dealflow Signals The Impact Alpha Impact Voices Podcasts Agents of Impact Open
What's Next Capital on the Frontier Measure Better Investing in Racial Equity Beyond Trade-offs Impact en las Americas New Revivalists
Local and Inclusive Climate Finance Catalytic Capital Frontier Finance Best Practices Geographies
Slack Agent of Impact Calls Events Contribute
The Archive ImpactSpace The Accelerator Selection Tool Network Map
About Us FAQ Calendar Pricing and Payment Policy Privacy Policy Terms of Service Agreement Contact Us
Locavesting Entrepreneurship Gender Smart Return on Inclusion Good Jobs Creative economy Opportunity Zones Investing in place Housing New Schooled Well Being People on the Move Faith and investing Inclusive Fintech
Clean Energy Farmer Finance Soil Wealth Conservation Finance Financing Fish
Innovative Finance
Personal Finance Impact Management
Africa Asia Europe Latin America Middle East Oceania/Australia China Canada India United Kingdom United States
Subscribe
Features
Series
Themes
Community
Data
Subscribe Log In
More

Investors back health-tech startups to manage diabetes around the world



ImpactAlpha, April 25 –  Real-time data and personalized feedback are the buzzwords of new diabetes-management ventures worldwide. Nearly 600 million people will develop diabetes by 2035. Two-thirds of new cases will be in low- and middle-income countries, driven by urbanization, changes in diet and and increasingly sedentary lifestyles. In the U.S., where as many as 100 million adults are diabetic or prediabetic, the annual cost burden is at least $266 billion.

Costs like that have attracted health-tech ventures that promise to reduce them through management and prevention. Livongo Health, based in Chicago, raised $105 million to drive behavior change by combining a blood glucose meter, a cloud-based “digital dashboard,” and real-time information and support for patients. General Catalyst and Kinnevik led the round, and were joined by corporate venture funds Merck Global Health Innovation Fund and Microsoft Ventures, along with DFJ, Kleiner Perkins Caufield & Byers, Sapphire Ventures, Zaffre Investments, 7wire Ventures and Echo Health Ventures.

In Spain and Mexico, SocialDiabetes is a popular smartphone app that integrates with glucometers from multiple providers. Patients can share their information with caregivers, doctors and insurance companies, who can track their progress through a real-time dashboard and help them adhere to treatment plans. Barcelona-based SocialDiabetes raised undisclosed funding from venture capital firm ALLVP. SocialDiabetes has partnerships with reinsurance firm MunichRE, medical-device maker Abbott and telecomm provider Vodafone.

You might also like...